07.14.26 -- iBio Aims To Complement GLP-1s By Preserving Muscle During Weight Loss With Myostatin Antibody

Physiologically based pharmacokinetic modeling is a powerful tool for clinical trial design that can be leveraged alongside early development experiments to reduce costs and accelerate timelines.

Gain insight into an automated high‑input workflow that streamlines long‑read whole‑genome library prep, supporting large DNA fragments while reducing reagent use.

Here, we used single B cell antibody discovery to rapidly identify a diverse set of potent, high-affinity VHH from immunized llamas against CD200R1, an emerging therapeutic immune checkpoint target.

Discover how chemomic analysis unlocks full DEL datasets to reveal early SAR trends, mechanism clues, and risks to help teams make data‑driven decisions and build stronger hit‑to‑lead foundations.

Take a look at how popular NMR prediction tools perform on complex natural products, revealing how algorithm choice, data depth, and modeling approaches impact ¹³C chemical shift accuracy.

Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.

Examine the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.